
Cátia Rebelo de Almeida
PhD candidate
Champalimaud Foundation
Lisbon, PTCátia Rebelo de Almeida is a PhD student in Cancer Development and Innate Immune Evasion Lab - Fior Lab (Champalimaud Foundation) and she is interested in molecularly exploring a potential angiogenesis-independent mechanism of action for anti-angiogenic therapies, namely bevacizumab.